| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 66 |
| 1 | ACETAMINOPHEN 500MG | 64 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 64 |
| 3 | PAIN RELIEVER | 64 |
| 4 | CAPECITABINE | 53 |
| 5 | TRASTUZUMAB | 47 |
| 6 | DEXAMETHASONE | 46 |
| 7 | DEXAMETHASONE 1.5 MG | 46 |
| 8 | PERTUZUMAB | 46 |
| 9 | PREGABALIN | 44 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ICHTHAMMOL OINTMENT | 2 | 0.0526 |
| 1 | PEGFILGRASTIM-BMEZ | 25 | 0.0412 |
| 2 | DROPERIDOL | 28 | 0.0167 |
| 3 | PECTIN | 1 | 0.0125 |
| 4 | CETYLPYRIDINIUM CHLORIDE | 6 | 0.0092 |
| 5 | HYALURONATE SODIUM | 13 | 0.0085 |
| 6 | CARBOXYMETHYLCELLULOSE SODIUM | 37 | 0.0065 |
| 7 | POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | 1 | 0.0055 |
| 8 | ADO-TRASTUZUMAB EMTANSINE | 38 | 0.0045 |
| 9 | EDOXABAN TOSYLATE | 30 | 0.0044 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 86 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 83 |
| 2 | Kinase Inhibitor [EPC] | 64 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 59 |
| 4 | Vitamin C [EPC] | 52 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 48 |
| 6 | Serotonin-3 Receptor Antagonist [EPC] | 47 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 43 |
| 8 | Fluoroquinolone Antibacterial [EPC] | 43 |
| 9 | Benzodiazepine [EPC] | 42 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 28 | 0.0036 |
| 1 | Cannabinoid [EPC] | 29 | 0.0036 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 30 | 0.0034 |
| 3 | Antiseptic [EPC] | 7 | 0.0016 |
| 4 | Aryl Hydrocarbon Receptor Agonist [EPC] | 2 | 0.0010 |
| 5 | Estrogen Receptor Antagonist [EPC] | 39 | 0.0010 |
| 6 | Epidermal Growth Factor Receptor Antagonist [EPC] | 43 | 0.0009 |
| 7 | Prostaglandin E1 Analog [EPC] | 14 | 0.0008 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 9 | 0.0007 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 48 | 0.0006 |